Amoxicillin

Overview

Amoxicillin is a broad-spectrum aminopenicillin antibiotic commonly used in dogs and cats for the treatment of a wide variety of bacterial infections. It is bactericidal and time-dependent, meaning its clinical efficacy depends on maintaining drug concentrations above the minimum inhibitory concentration (MIC) of susceptible bacteria for an adequate duration.

In small animal practice, amoxicillin is widely used as a first-line antimicrobial for uncomplicated infections caused by non–beta-lactamase–producing organisms, including urinary tract infections, skin and soft tissue infections, respiratory infections, and certain gastrointestinal infections. Because it is better absorbed orally than ampicillin, amoxicillin often achieves higher serum concentrations after oral administration in dogs and cats.

Mechanism of Action (MOA): Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins involved in mucopeptide formation. This results in a defective cell wall, osmotic instability, and bacterial cell death. Like other beta-lactam antibiotics, amoxicillin is most effective against actively dividing bacteria and is inactive against organisms that produce beta-lactamase enzymes unless combined with a beta-lactamase inhibitor.

Indications

Amoxicillin is indicated in dogs and cats for the treatment of infections caused by susceptible, non–beta-lactamase–producing bacteria. It is FDA-approved for oral use in small animals and is commonly selected as a first-line antimicrobial for uncomplicated infections when culture and susceptibility data support its use.

• Urinary tract infections: Effective for uncomplicated bacterial cystitis caused by susceptible organisms such as Escherichia coli, Streptococcus spp, Staphylococcus spp, and Proteus mirabilis.
• Skin and soft tissue infections: Used for treatment of wounds, abscesses, cellulitis, and superficial bacterial dermatitis caused by susceptible gram-positive organisms.
• Respiratory tract infections: Indicated for infections of the upper and lower respiratory tract, including tonsillitis and tracheobronchitis, when caused by susceptible bacteria.
• Gastrointestinal infections: Used for bacterial gastroenteritis caused by susceptible organisms and as part of combination therapy for Helicobacter spp–associated gastritis.
• Systemic bacterial infections: Employed in extra-label protocols for susceptible systemic infections when culture results or clinical judgment support its use.
• Empirical antimicrobial therapy: May be used initially for mild to moderate infections in dogs and cats when resistance is not suspected; amoxicillin-clavulanate is preferred if beta-lactamase–producing organisms are a concern.

Dosage (Reference)

Dog

In dogs, amoxicillin is administered orally for the treatment of susceptible bacterial infections. Dosage and duration depend on the type and severity of infection, as well as clinical response.

Cat

In cats, amoxicillin is commonly used for susceptible bacterial infections and is available in tablet and oral suspension forms. Dosing may be calculated per kg or as a fixed dose per cat, depending on formulation and indication.

Warnings & Precautions

Amoxicillin is generally considered a safe and well-tolerated antibiotic in dogs and cats; however, appropriate patient selection, dosing, and monitoring are essential to minimize adverse reactions and treatment failure.

• Hypersensitivity reactions: Contraindicated in dogs and cats with a known history of hypersensitivity to penicillins. Cross-reactivity may occur in patients allergic to other beta-lactam antibiotics (eg, cephalosporins).
• Severe systemic illness: Oral administration should be avoided in patients with septicemia, shock, or severe systemic disease, as gastrointestinal absorption may be delayed or unreliable; parenteral therapy is preferred in these cases.
• Renal disease: Use cautiously in patients with impaired renal function, particularly when using higher doses or prolonged therapy, as the drug is primarily eliminated unchanged by the kidneys.
• GI sensitivity: Gastrointestinal upset may occur, especially with oral dosing. Administration with food may reduce nausea, vomiting, or anorexia.
• Alteration of normal flora: Use may disrupt normal intestinal microflora, potentially leading to antibiotic-associated diarrhea or overgrowth of resistant bacteria with prolonged use.
• Neurologic effects: High doses or prolonged administration may be associated with neurotoxicity (eg, ataxia), particularly in dogs.
• Hepatic considerations: Although not considered hepatotoxic, increases in liver enzyme activities have been reported; use with caution in patients with preexisting hepatic disease.
• Antimicrobial stewardship: Amoxicillin should be used only when bacterial infection is suspected or confirmed, and culture and susceptibility testing should be considered, especially for recurrent or nonresponsive infections.
• Pregnancy and lactation: Use only when the potential benefits outweigh the risks, as safety during pregnancy and lactation has not been firmly established in dogs and cats.

Drug Interactions

The following drug interactions with amoxicillin have been reported or are theoretical in dogs and cats. Concurrent use is not always contraindicated, but potential risks should be considered and appropriate monitoring performed when necessary.

• Aminoglycosides (eg, amikacin, gentamicin): Beta-lactam antibiotics may inactivate aminoglycosides when mixed in vitro and potentially in vivo, especially in patients with renal disease. Avoid mixing in the same syringe or IV line.
• Bacteriostatic antimicrobials (eg, chloramphenicol, macrolides, sulfonamides, tetracyclines): In vitro antagonism with beta-lactam antibiotics has been reported. Clinical significance is unclear, but concurrent use is generally discouraged unless clearly indicated.
• Methotrexate: Amoxicillin may reduce renal excretion of methotrexate, increasing serum concentrations and the risk of methotrexate toxicity.
• Mycophenolate: Concurrent administration may decrease concentrations of mycophenolate by reducing levels of its active metabolite.
• Probenecid: Inhibits renal tubular secretion of penicillins, leading to increased serum concentrations and prolonged half-life of amoxicillin.
• Warfarin: Concurrent use may increase the risk of bleeding due to potentiation of anticoagulant effects; careful monitoring is recommended.

Side Effects & Overdose

Side Effects

Adverse effects associated with amoxicillin in dogs and cats are generally uncommon and usually mild. Most reactions are related to gastrointestinal upset or hypersensitivity and are not dose-dependent.

• Gastrointestinal effects: Anorexia, vomiting, and diarrhea may occur following oral administration. Antibiotic-associated diarrhea can result from alteration of normal gut flora and overgrowth of resistant bacteria.
• Hypersensitivity reactions: Rare but potentially serious reactions may include skin rashes, fever, eosinophilia, neutropenia, thrombocytopenia, lymphadenopathy, anemia, or anaphylaxis.
• Superinfection: Disruption of normal intestinal flora may allow proliferation of resistant organisms, particularly with prolonged therapy.
• Neurologic effects: Ataxia and other neurologic signs have been reported in dogs receiving high doses or prolonged courses of penicillins.
• Hepatic effects: Penicillins are not considered hepatotoxic, but mild elevations in liver enzyme activities have been reported.
• Cardiorespiratory effects: Rarely, tachypnea, dyspnea, edema, and tachycardia have been observed in dogs.

Overdose

Acute oral overdose of amoxicillin in dogs and cats is unlikely to result in severe toxicity. Most cases involve mild gastrointestinal signs; however, more serious effects may occur with very high dosages or in patients with renal impairment.

• Gastrointestinal distress: Vomiting, diarrhea, and anorexia are the most common signs following overdose.
• Central nervous system effects: Extremely high parenteral doses, particularly in patients with renal disease, may result in neurologic signs such as ataxia or seizures.
• Management: Treatment is primarily supportive and symptomatic. Ensure adequate hydration and monitor for progression of clinical signs.
• Poison consultation: In suspected or confirmed overdose cases, consultation with a 24-hour veterinary poison control center is recommended.

Key Notes

Practical clinical points to optimize the effective and responsible use of amoxicillin in dogs and cats:

• Time-dependent activity: Amoxicillin efficacy depends on maintaining drug concentrations above the minimum inhibitory concentration (MIC); adherence to proper dosing intervals is critical for success.
• First-line antimicrobial: Appropriate as an initial choice for infections caused by susceptible, non–beta-lactamase–producing bacteria, particularly uncomplicated urinary and soft tissue infections.
• Culture-based use: Whenever possible, bacterial culture and susceptibility testing should guide therapy, especially for recurrent or non-responsive infections.
• Renal elimination: Because the drug is primarily excreted unchanged in urine, dose adjustment or closer monitoring may be required in patients with renal disease.
• Combination therapy: When resistance due to beta-lactamase production is suspected, amoxicillin–clavulanate is generally preferred over amoxicillin alone.
• Incomplete courses: Premature discontinuation increases the risk of treatment failure and antimicrobial resistance, even if clinical signs resolve early.
• Antimicrobial stewardship: Amoxicillin is classified as a critically important antimicrobial in human medicine; judicious use in veterinary patients is strongly recommended.